GB1260464A - 11beta-HALO-STEROIDS - Google Patents
11beta-HALO-STEROIDSInfo
- Publication number
- GB1260464A GB1260464A GB456968A GB456968A GB1260464A GB 1260464 A GB1260464 A GB 1260464A GB 456968 A GB456968 A GB 456968A GB 456968 A GB456968 A GB 456968A GB 1260464 A GB1260464 A GB 1260464A
- Authority
- GB
- United Kingdom
- Prior art keywords
- chloro
- compositions
- steroids
- methylpregna
- dione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 abstract 3
- 239000003433 contraceptive agent Substances 0.000 abstract 2
- 230000002254 contraceptive effect Effects 0.000 abstract 2
- 230000003054 hormonal effect Effects 0.000 abstract 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 229930193140 Neomycin Natural products 0.000 abstract 1
- 230000001195 anabolic effect Effects 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000000022 bacteriostatic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 229960004927 neomycin Drugs 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000007935 oral tablet Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000001072 progestational effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB456968A GB1260464A (en) | 1968-01-29 | 1968-01-29 | 11beta-HALO-STEROIDS |
| NL6901341A NL6901341A (enrdf_load_stackoverflow) | 1968-01-29 | 1969-01-28 | |
| DE19691904324 DE1904324A1 (de) | 1968-01-29 | 1969-01-29 | Steroide und Verfahren zu ihrer Herstellung |
| DK46469A DK130646B (da) | 1968-01-29 | 1969-01-29 | Analogifremgangsmåde til fremstilling af 17- og/eller 21-alkanoyloxy-11beta-klor-16beta-metylpregna-1,4-dien-3,20-dioner. |
| FR6901752A FR2000923A1 (enrdf_load_stackoverflow) | 1968-01-29 | 1969-01-29 | |
| CH138569A CH547789A (de) | 1968-01-29 | 1969-01-29 | Verfahren zur herstellung von in 9,11(alpha)- und 12-stellung unsubstituierten 11(beta)-chlor- bzw. 11(beta)-brom-9(alpha)-steroiden. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB456968A GB1260464A (en) | 1968-01-29 | 1968-01-29 | 11beta-HALO-STEROIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1260464A true GB1260464A (en) | 1972-01-19 |
Family
ID=9779625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB456968A Expired GB1260464A (en) | 1968-01-29 | 1968-01-29 | 11beta-HALO-STEROIDS |
Country Status (6)
| Country | Link |
|---|---|
| CH (1) | CH547789A (enrdf_load_stackoverflow) |
| DE (1) | DE1904324A1 (enrdf_load_stackoverflow) |
| DK (1) | DK130646B (enrdf_load_stackoverflow) |
| FR (1) | FR2000923A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1260464A (enrdf_load_stackoverflow) |
| NL (1) | NL6901341A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3591689A (en) * | 1969-06-04 | 1971-07-06 | Mead Johnson & Co | Progestational composition in oral dosage form |
-
1968
- 1968-01-29 GB GB456968A patent/GB1260464A/en not_active Expired
-
1969
- 1969-01-28 NL NL6901341A patent/NL6901341A/xx unknown
- 1969-01-29 CH CH138569A patent/CH547789A/xx not_active IP Right Cessation
- 1969-01-29 DE DE19691904324 patent/DE1904324A1/de active Pending
- 1969-01-29 FR FR6901752A patent/FR2000923A1/fr not_active Withdrawn
- 1969-01-29 DK DK46469A patent/DK130646B/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2000923A1 (enrdf_load_stackoverflow) | 1969-09-19 |
| DK130646B (da) | 1975-03-17 |
| DK130646C (enrdf_load_stackoverflow) | 1975-08-25 |
| CH547789A (de) | 1974-04-11 |
| DE1904324A1 (de) | 1969-09-11 |
| NL6901341A (enrdf_load_stackoverflow) | 1969-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO1250B1 (en) | New pharmaceutical preparations | |
| IE39957B1 (en) | Steroid formulation | |
| IE41287L (en) | Steroid pharmaceutical composition | |
| GB1260464A (en) | 11beta-HALO-STEROIDS | |
| DK120190B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner. | |
| GB1403962A (en) | Anti-inflammatory pregnane derivative | |
| ZA744750B (en) | 16-methyl-pregna-1,4,9 (11)-triene-3,20-diones as medicaments- new processes for the preparation of these products, and pharmaceutical compositions | |
| IE33207L (en) | Pharmaceutical compositions containing diazacarbazole | |
| GB1260463A (en) | 11beta-BROMO-19-NOR-STEROIDS | |
| AU476623B2 (en) | 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof | |
| GB1527061A (en) | Anti-inflammatory compositions containing steroids | |
| ES380698A2 (es) | Un procedimiento para la preparacion de nuevos esteroides anti-inflamatorios de la serie del pregnano. | |
| ES388852A1 (es) | Un metodo para producir nuevos compuestos de 16-metilen-9 beta, 10 alfa-esteroide. | |
| IL36608A (en) | 16alpha,17alpha-dihydroxy-21-fluoro-pregna-4,6-diene-3,20-diones and derivatives thereof,their manufacture and pharmaceutical compositions containing them | |
| CA880871A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 6-METHYL-16-METHYLENE-17.alpha.-HYDROXY-4,6-PREGNADIENE-3,20-DIONE 17-ACETATE | |
| CA739462A (en) | 3-keto unsaturated steroid compounds, compositions containing same and process for the preparation thereof | |
| IL32936A0 (en) | Androstane and pregnane derivatives and pharmaceutical compositions containing them | |
| CA792234A (en) | DIESTERS OF 9.alpha.,11.beta.-DIHALO-16.alpha.-ALKYL-17.alpha.,21-DIHYDROXY STEROIDS OF THE PREGNANE SERIES | |
| CA785275A (en) | 17.alpha.-(4-ALKOXY-3-BUTEN-1-YNYL)ESTRA-1,3,5(10)-TRIENE-3, 17.beta.-DIOLS, DERIVATIVES THEREOF, AND PROCESS FOR THEIR PREPARATION | |
| CA596004A (en) | 21-BROMO-3.beta.,17.alpha.-DIHYDROXY-11,20-DIKETO PREGNANE AND ALLOPREGNANE AND PREPARATION | |
| CA701108A (en) | 1,4,6-PREGNATRIENE-11.beta.,17.alpha.,21-DIOL-3,20-DIONE AND 21-ESTERS | |
| AT284351B (de) | Verfahren zur Herstellung des neuen 19-Nor-pregna-1,3,5(10)-trien-3,20-diols und dessen neuer 3,20-di-nieder-Alkanoyl-, 3-nieder-Alkyl- und 3-nieder-Alkyl-20-nieder-alkanoyl-Derivate | |
| CA715539A (en) | COMPOSITIONS CONTAINING 6.alpha.-FLUORO PREDNISOLONE AND 21-ACETATE | |
| CA1033717A (en) | 6.alpha.,7.alpha.-DIHYDRO-3'H-CYCLOPROPA(6,7)PREGNA-4,6-DIENE-3,15,20-TRIONE AND RELATED COMPOUNDS | |
| CA615185A (en) | 16.beta.-METHYL-1,4-PREGNADIENE-9,11-OXIDO-17.alpha.,21-DIOL-3,20-DIONE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |